HEINEMAN THOMAS CHARLES (Chief Medical Officer) purchased 4.5% of their position (12.13K shares) of ONCOLYTICS BIOTECH INC on the open market
Open‑market purchase worth $10.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/13/2026ACC: 0001493152-26-006544
Officer· Chief Medical Officer
Since Feb 2026
+12.13K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.13K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+12.13K
Price / share
$0.83
Trade value
$10.03K
% of position
4.5%
2/12/2026
270.69K→282.82K
Total
Net shares
+12.13K
Net value
$10.03K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/12/2026 | P · Purchase | +12.13K | $0.83 | $10.03K | 4.5% | 270.69K | 282.82K |
| Total | +12.13K | $10.03K | ||||||
Derivative Transactions0
No derivative transactions reported